Why the Senate's pending compounding bill will safeguard patients

08/12/2013 | Washington Post (tiered subscription model), The

Legislation in the Senate can help bolster the safety of compounded drugs by clarifying the obligations of the FDA and state regulatory agencies and by differentiating traditional compounding pharmacies from drug factories disguised as pharmacies, writes National Association of Boards of Pharmacy Executive Director Carmen Catizone.

View Full Article in:

Washington Post (tiered subscription model), The

Published in Brief: